Biological activity of activating thyrotrophin receptor mutants: Modulation by iodide

Journal of Molecular Endocrinology

Volumn 34, Issue 1, 2005, Pages 209-220

  Al Khafaji, F ^a   Wiltshire, M ^a   Fuhrer, D ^b   Mazziotti, G ^c   Lewis, M D ^a   Smith, P J ^a   Ludgate, Marian ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IODIDE; THYROTROPIN; THYROTROPIN RECEPTOR;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL CULTURE; CELL CYCLE G2 PHASE; CELL DEATH; CELL GROWTH; CELL MUTANT; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE DISRUPTION; GENE MUTATION; GOITER; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

ADENYLATE CYCLASE; ANIMALS; APOPTOSIS; CELL CYCLE; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; IODIDES; MUTATION; NECROSIS; OSMOTIC PRESSURE; PHOSPHORYLATION; RATS; RECEPTORS, THYROTROPIN; THYROID GLAND; THYROTROPIN;

EID: 14544305645     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01590     Document Type: Article

References (27)

1. Alberti L, Proverbio MC, Costagliola S, Weber G, Beck-Peccoz P, Chiumello G & Persani L. 2001 A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism. European Journal of Endocrinology 145 249-254.
2. Ashworth RJ, Ham J & Cockle SM 1994 The effects of pyroglutamyl-glutamylprolineamide, a peptide related to thyrotrophin releasing hormone, on rat anterior pituitary cells in culture. Journal of Endocrinology 142 111-118.
3. Armstrong R, Wen W, Meinkoth J, Taylor S & Montminy M 1995 A refractory phase in cyclic AMP responsive transcription requires down-regulation of protein kinase A. Molecular and Cellular Biology 15 1826-1832.
4. Becks PB, Eggo MC & Burrow GN 1988 Organic iodide inhibits deoxyribonucleic acid synthesis and growth in FRTL-5 thyroid cells. Endocrinology 123 545-551.
5. 2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. Journal of Clinical Endocrinology and Metabolism 79 152-159.
6. Dugrillon A, Bechtner G, Uedelhoven W, Weber P & Gartner R 1990 Evidence that an iodolactone mediates the inhibitory effect of iodide on thyroid-cell proliferation but not on adenosine-3′,5′-monophosphate formation. Endocrinology 127 337-343.
7. Duprez L, Parma J, Van Sande J, Allgeier A, Leclere J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J & Vassart G 1994 Germline mutations in the thyrotropin receptor gene cause nonautoimmune autosomal dominant hyperthyroidism. Nature Genetics 7 396-401.
8. Duprez L, Hermans J, Van Sande J, Dumont JE, Vassart G & Parma J 1997 Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene. Journal of Clinical Endocrinology and Metababolism 82 306-308.
9. Esapa C, Foster S, Johnson S, Jameson JL, Kendall Taylor P & Harris PE 1997 G protein and thyrotropin receptor mutations in thyroid neoplasia. Journal of Clinical Endocrinology and Metabolism 82 493-496.
10. Fuhrer D, Lewis MD, Alkhafaji F, Starkey K, Paschke R, Wynford-Thomas D, Eggo M & Ludgate M 2003 Biological activity of activating TSHR mutants depends on the cellular context. Endocrinology 144 4018-4030.
11. Holzapfel HP, Fuhrer D, Wonerow P, Weinland G, Scherbaum WA & Paschke R 1997 Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiter. Journal of Clinical Endocrinology and Metabolism 82 4229-4233.
12. Krohn K & Paschke R 2001 Progress in understanding the etiology of thyroid autonomy. Journal of Clinical Endocrinology and Metabolism 86 3336-3345.
13. Laurberg P, Pedersen KM, Vestergaard H & Sigurdsson G 1991 High-incidence of multinodular toxic goiter in the elderly population in a low iodine intake area vs high-incidence of Graves disease in the young in a high iodine intake area - comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. Journal of Internal Medicine 229 415-420.
14. 3 cells. Journal of Neuroendocrinology 14 361-367.
15. Panneels V, Van Sande J, Vandenbergen H, Jacoby C, Braekman JC, Dumont JE & Boeynaems JM 1994 Inhibition of human thyroid adenylyl-cyclase by 2-iodoaldehydes. Molecular and Cellular Endocrinology 106 41-50.
16. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J & Vassart G 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365 649-651.
17. 2+ cascades. Molecular Endocrinology 9 725-733.
18. Parma J, Duprez L, Van Sande J, Cochaux P, Hermans J, Rocmans P, VanVliet G, Costagliola S, Rodien P, Dumont J & Vassart G 1997 Diversity and prevalence of somatic mutations in the thyrotropin receptor and G(s) alpha genes as a cause of toxic adenoma. Journal of Clinical Endocrinology and Metabolism 82 2695-2701.
19. Paschke R & Ludgate M 1997 The thyrotropin receptor in thyroid disease. New England Journal of Medicine 337 1675-1681.
20. Smerdely P, Pitsiavas V & Boyages SC 1993 Evidence that the inhibitory effects of iodide on thyroid cell proliferation are due to arrest of the cell-cycle at G0 G1 and G2 M phases. Endocrinology 133 2881-2888.
21. Smerdely P, Pitsiavas V & Boyages SC 1995 The G(2)M arrest caused by iodide is unrelated to the effects of iodide at adenylate cyclase. Thyroid 5 325-330.
22. Tonacchera M, Chiovato L, Pinchera A, Agretti P, Fiore E, Cetani F, Rocchi R, Viacava P, Miccoloi P & Vitti P 1998 Hyperfunctioning thyroid nodules in toxic mulitnodular goitre share activating thyrotropin receptor mutations with solitary toxic adenoma. Journal of Clinical Endocrinology and Metabolism 83 492-498.
23. Trulzsch B, Krohn K, Wonerow P, Chey S, Holzapfel HP, Ackermann F, Fuhrer D & Paschke R 2001 Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. Journal of Molecular Medicine 78 684-691.
24. Van Sande J, Cochaux P & Dumont JE 1985 Further characterization of the iodide inhibitory effect on the cAMP system in dog thyroid slices. Molecular and Cellular Endocrinology 40 181-187.
25. Vermes I, Haanen C, Steffens-Nakken H & Reutelingsperger C 1995 A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labeled annexin V. Journal of Immunological Methods 184 39-51.
26. Villone G, DeAmicis F, Veneziani BM, Salzano S, DiCarlo A & Tramontano D 1997 Sustained versus transient cyclic AMP intracellular levels: effect on thyrotropin dependent growth of thyroid cells. Cell Growth and Differentiation 8 1181-1188.
27. Vitale M, Di Matola T, D'Ascoli F, Salzano S, Bogazzi F, Fenzi G, Martino E & Rossi G 2000 Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. Endocrinology 141 598-605.